Cyclerion Therapeutics

CYCN • NASDAQ • Stock Fundamentals

Cyclerion Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Regina Graul, with a market cap of $13.9M.

Market Cap$13.9M

Employees1.0

CEORegina Graul

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026

Next EarningsAug 4, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Cyclerion Therapeutics

Cyclerion Therapeutics (CYCN) has a market capitalization of $13.9M and trades on NASDAQ.

Cyclerion Therapeutics has approximately 1 employees.